Summary: Fifty percent of patients treated for mild COVID-19 infections still had the virus up to eight days after symptoms disappeared. Findings suggest patients can remain infectious, even after symptomatic recovery. Source: American Thoracic Society In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection,” Lixin Xie, MD, Lokesh Sharma, PhD, and co-authors report on a study of 16 patients with COVID-19, who were treated and released from the Treatment Center of PLA General Hospital in Beijing between January 28 and Feb. 9, 2020. Patients studied had a median age of 35.5 years. Researchers collected samples from throat swabs taken from all patients on alternate days and analyzed. Patients were discharged after their recovery and confirmation of negative viral status by at least two consecutive polymerase chain reaction (PCR) tests. “The most significant finding from our study is that half of the patients kept shedding the virus even after resolution of their symptoms,” said co-lead author Dr. Sharma, instructor of medicine, Section of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, Yale School of Medicine. “More severe infections may have even longer shedding times.” The primary symptoms in these patients included fever, cough, pain in the pharynx (pharyngalgia) and difficult or labored breathing (dyspnea). Patients were treated with a range of medications. The time from infection to onset of symptoms (incubation period) was five days among all but one patient. The average duration of symptoms was eight days, while the length of time patients remained contagious after the end of their symptoms ranged from one to eight days. Two patients had diabetes and one had tuberculosis, neither of which affected the timing of the course of COVID-19 infection. “If you had mild respiratory symptoms from COVID-19 and were staying at home so as not to infect people, extend your quarantine for another two weeks after recovery to ensure that you don’t infect other people,” recommended corresponding author Lixin Xie, MD, professor, College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing. Researchers collected samples from throat swabs taken from all patients on alternate days and analyzed. Patients were discharged after their recovery and confirmation of negative viral status by at least two consecutive polymerase chain reaction (PCR) tests. The image is in the public domain. The authors had a special message for the medical community: “COVID-19 patients can be infectious even after their symptomatic recovery, so treat the asymptomatic/recently recovered patients as carefully as symptomatic patients.” The researchers emphasized that all of these patients had milder infections and recovered from the disease, and that the study looked at a small number of patients. They noted that it is unclear whether similar results would hold true for more vulnerable patients such as the elderly, those with suppressed immune systems and patients on immunosuppressive therapies. “Further studies are needed to investigate if the real-time PCR-detected virus is capable of transmission in the later stages of COVID-19 infection,” Dr. Xie added. [divider]About this neuroscience research article[/divider]See alsoFeaturedNeurologyNeuroscience·February 27, 2020The Brain and Climate Change Source: American Thoracic Society Media Contacts: Dacia Morris – American Thoracic Society Image Source: The image is in the public domain. Original Research: Open access (PDF) “Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection”. De Chang ; Guoxin Mo , Xin Yuan , Yi Tao , Xiaohua Peng , Fusheng Wang , Lixin Xie , Lokesh Sharma , Charles S Dela Cruz , and Enqiang Qin. American Journal of Respiratory and Critical Care Medicine doi:10.1164/rccm.202003-0524LE. Abstract Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection SARS-CoV-2 (previously 2019-nCoV) has infected >167,000 patients and killed >6600 people. It has been reported that a patient in Germany had high viral titers after the resolution of fever and infected two of the close contacts after the resolution of symptoms. In the wake of these cases, it is still unclear how long the patient was virus positive after the resolution of the symptoms. In this study, we aimed to determine the time kinetics of viral clearance in reference to the resolution of symptoms in 16 patients treated in Beijing, China, and show that half of the patients with COVID-19 were viral positive even after resolution of their symptoms. [divider]Feel Free To Share This Neuroscience News.[/divider] Join our Newsletter I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information ) Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.comWe hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.